155
Views
0
CrossRef citations to date
0
Altmetric
Review

Current management of familial adenomatous polyposis

, , , , , , , , & show all
Pages 363-377 | Received 01 Dec 2023, Accepted 15 Apr 2024, Published online: 26 May 2024

References

  • Clark SK. Management of genetically determined colorectal cancer. Surgeon. 2019 Jun;17(3):165–171. doi: 10.1016/j.surge.2019.03.003
  • Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis. 2009;4(1):22. doi: 10.1186/1750-1172-4-22
  • Signoroni S, Vitellaro M, Sala P, et al. Biomarkers in familial adenomatous polyposis: role and significance. Front Biosci (Schol Ed). 2010 Jan 1;2(2):413–421. doi: 10.2741/s74
  • Aghabozorgi AS, Ebrahimi R, Bahiraee A, et al. The genetic factors associated with Wnt signaling pathway in colorectal cancer. Life Sci. 2020 Sep 1;256:118006. doi: 10.1016/j.lfs.2020.118006
  • Short E, Sampson J. The role of inherited genetic variants in colorectal polyposis syndromes. Adv Genet. 2019;103:183–217.
  • Cavestro GM, Mannucci A, Balaguer F, et al. Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines. Clin Gastroenterol Hepatol. 2023 Mar;21(3):581–603 e33. doi: 10.1016/j.cgh.2022.12.006
  • Urso EDL, Ponz de Leon M, Vitellaro M, et al. Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement. Dig Liver Dis. 2021 Apr;53(4):409–417.
  • Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol. 2007 Feb;61(2):153–161. doi: 10.1016/j.critrevonc.2006.07.004
  • Tudyka VN, Clark SK. Surgical treatment in familial adenomatous polyposis. Ann Gastroenterol. 2012;25(3):201–206.
  • Giardiello FM, Krush AJ, Petersen GM, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology. 1994 Jun;106(6):1542–1547.
  • Cavallo D, Ballardini G, Ferrari A, et al. Wireless capsule endoscopy in adolescents with familial adenomatous polyposis. Tumori. 2016;102(1):40–44. doi: 10.5301/tj.5000390
  • Monahan KJ, Bradshaw N, Dolwani S, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2020 Mar;69(3):411–444.
  • Weiss JM, Gupta S, Burke CA, et al. NCCN Guidelines(R) Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1. 2021. J Natl Compr Canc Netw. 2021 Oct 15;19(10):1122–1132. doi: 10.1164/jnccn.2021.0048
  • Nusliha A, Dalpatadu U, Amarasinghe B, et al. Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience. BMC Res Notes. 2014 Oct 18;7(1):734. doi: 10.1186/1756-0500-7-734
  • Massimino M, Signoroni S, Boschetti L, et al. Medulloblastoma and familial adenomatous polyposis: Good prognosis and good quality of life in the long-term? Pediatr Blood Cancer. 2021 Jan 18;68(4):e28912. doi: 10.1002/pbc.28912
  • Eizuka M, Toya Y, Kosaka T, et al. Attenuated familial adenomatous polyposis. Intern Med. 2023 Sep 15;62(18):2651–2654. doi: 10.2169/internalmedicine.1101-22
  • Iwatsuki M, Matsumoto C, Mimori K, et al. The comprehensive review of gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) from diagnosis and treatment. Ann Gastroenterol Surg. 2023 Sep;7(5):725–732.
  • Paramythiotis D, Kyriakidis F, Karlafti E, et al. A rare case of multiple gastrointestinal stromal tumors coexisting with a rectal adenocarcinoma in a patient with attenuated familial adenomatous polyposis syndrome and a mini review of the literature. Medicina (Kaunas). 2022 Aug 18;58(8). doi: 10.3390/medicina58081116
  • Church J, Burke C, McGannon E, et al. Predicting polyposis severity by proctoscopy: how reliable is it? [Evaluation Studies]. Dis Colon Rectum. 2001 Sep;44(9):1249–1254.
  • Tonelli F, Valanzano R, Monaci I, et al. Restorative proctocolectomy or rectum-preserving surgery in patients with familial adenomatous polyposis: results of a prospective study. World J Surg. 1997 Jul;21(6):653–658. discussion 659. doi: 10.1007/s002689900289
  • Debinski HS, Love S, Spigelman AD, et al. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology. 1996 Apr;110(4):1028–1030.
  • Hyer W, Cohen S, Attard T, et al. Management of familial adenomatous polyposis in children and adolescents: position paper from the ESPGHAN polyposis working group. J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):428–441.
  • Pasquer A, Benech N, Pioche M, et al. Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis. Endosc Int Open. 2021 Jul;9(7):E1014–E1022.
  • Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008 May;57(5):704–713. doi: 10.1136/gut.2007.136127
  • Vitellaro M, Sala P, Signoroni S, et al. Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. Br J Surg. 2014 Apr;101(5):558–565. doi: 10.1002/bjs.9411
  • Bjork J, Akerbrant H, Iselius L, et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology. 2001 Nov;121(5):1127–1135.
  • Bisgaard ML, Ripa R, Knudsen AL, et al. Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut. 2004 Feb;53(2):266–270.
  • Lynch PM, Morris JS, Wen S, et al. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016 Jul;84(1):115–125 e4.
  • Campos FG. Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. World J Gastroenterol. 2014 Nov 28;20(44):16620–16629. doi: 10.3748/wjg.v20.i44.16620
  • Kyriakidis F, Kogias D, Venou TM, et al. Updated perspectives on the diagnosis and management of familial adenomatous polyposis. Appl Clin Genet. 2023;16:139–153. doi: 10.2147/TACG.S372241
  • Sanchez-Mete L, Stigliano V. Update on small bowel surveillance in hereditary colorectal cancer syndromes. Tumori. 2019 Feb;105(1):12–21. doi: 10.1177/0300891618792461
  • Dunlop MG. British Society for G, Association of Coloproctology for Great B, et al. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut. 2002 Oct;51(Suppl 5(Suppl 5)):V21–7. doi: 10.1136/gut.51.suppl_5.v21
  • Vitellaro M, Piozzi G, Signoroni S, et al. Short-term and long-term outcomes after preventive surgery in adolescent patients with familial adenomatous polyposis. Pediatr Blood Cancer. 2020 Mar;67(3):e28110.
  • Nugent KP, Phillips RK, Hodgson SV, et al. Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut. 1994 Nov;35(11):1622–1623.
  • Levin B, Barthel JS, Burt RW, et al. Colorectal cancer screening clinical practice Guidelines. J Natl Compr Canc Netw. 2006 Apr;4(4):384–420.
  • Vitellaro M, Ferrari A, Trencheva K, et al. Is laparoscopic surgery an option to support prophylactic colectomy in adolescent patients with Familial Adenomatous Polyposis (FAP)? Pediatr Blood Cancer. 2012 Dec 15;59(7):1223–1228. doi: 10.1002/pbc.24113
  • Ardoino I, Signoroni S, Malvicini E, et al. Long-term survival between total colectomy versus proctocolectomy in patients with FAP: a registry-based, observational cohort study. Tumori. 2020 Apr;106(2):139–148.
  • Nguyen TH, Chokshi RV. Low anterior resection syndrome. Curr Gastroenterol Rep. 2020 Aug 4;22(10):48. doi: 10.1007/s11894-020-00785-z
  • Vitellaro M, Bonfanti G, Sala P, et al. Laparoscopic colectomy and restorative proctocolectomy for familial adenomatous polyposis. Surg Endosc. 2011 Jun;25(6):1866–1875.
  • Lauricella S, Peyser D, Carrano FM, et al. Intraluminal anastomotic assessment using indocyanine green near-infrared imaging for left-sided colonic and rectal resections: a systematic review. J Gastrointest Surg. 2023 Mar;27(3):615–625.
  • Rausa E, Zappa MA, Kelly ME, et al. A standardized use of intraoperative anastomotic testing in colorectal surgery in the new millennium: is technology taking over? A systematic review and network meta-analysis. Tech Coloproctol. 2019 Jul;23(7):625–631.
  • Trencheva K, Morrissey KP, Wells M, et al. Identifying important predictors for anastomotic leak after colon and rectal resection: prospective study on 616 patients. Ann Surg. 2013 Jan;257(1):108–113.
  • Rausa E, Colletti G, Ciniselli CM, et al. Superior rectal artery preservation to reduce anastomotic leak rates in familial adenomatous polyposis patients treated with total colectomy and ileorectal anastomosis. Tech Coloproctol. 2023 Dec;27(12):1327–1334. doi: 10.1007/s10151-023-02858-3
  • Ishikawa H, Yamada M, Sato Y, et al. Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis (J-FAPP Study III): a multicenter prospective interventional study. Endoscopy. 2023 Apr;55(4):344–352.
  • Takeuchi Y, Hamada K, Nakahira H, et al. Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study. Endoscopy. 2023 Jun;55(6):515–523.
  • Sinha A, Tekkis PP, Rashid S, et al. Risk factors for secondary proctectomy in patients with familial adenomatous polyposis. Br J Surg. 2010 Nov;97(11):1710–1715.
  • Minegishi Y, Kudo SE, Miyata Y, et al. Comprehensive diagnostic performance of real-time characterization of colorectal lesions using an artificial intelligence–assisted system: a prospective study. Gastroenterology. 2022 Jul;163(1):323–325.e3.
  • Kominami Y, Yoshida S, Tanaka S, et al. Computer-aided diagnosis of colorectal polyp histology by using a real-time image recognition system and narrow-band imaging magnifying colonoscopy. Gastrointest Endosc. 2016 Mar;83(3):643–649.
  • Dornblaser D, Young S, Shaukat A. Colon polyps: updates in classification and management. Curr Opin Gastroenterol. 2023 Nov 2;40(1):14–20. doi: 10.1097/MOG.0000000000000988
  • Vadhwana B, Tarazi M, Patel V. The role of artificial intelligence in prospective real-time histological prediction of colorectal lesions during colonoscopy: a systematic review and meta-analysis. Diagn (Basel). 2023 Oct 20;13(20):3267. doi: 10.3390/diagnostics13203267
  • Hopper AD. Role of endoscopy in patients with familial adenomatous polyposis. Frontline Gastroenterol. 2022;13(e1):e72–e79. doi: 10.1136/flgastro-2022-102125
  • Saurin JC, Napoleon B, Gay G, et al. Endoscopic management of patients with familial adenomatous polyposis (FAP) following a colectomy. Endoscopy. 2005 May;37(5):499–501.
  • van Leerdam ME, Roos VH, van Hooft JE, et al. Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019 Sep;51(9):877–895.
  • Atallah S, Martin-Perez B, Albert M, et al. Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol. 2014 May;18(5):473–480.
  • Carmichael H, Sylla P. Evolution of Transanal Total Mesorectal Excision. Clin Colon Rectal Surg. 2020 May;33(3):113–127. doi: 10.1055/s-0039-3402773
  • Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol. 2007 Feb;17(2):379–389. doi: 10.1007/s00330-006-0388-x
  • Koskenvuo L, Renkonen-Sinisalo L, Jarvinen HJ, et al. Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis. Int J Colorectal Dis. 2014 Feb;29(2):225–230.
  • M’Koma AE, Herline AJ, Adunyah SE. Subsequent adenomas of ileal pouch and anorectal segment after prophylactic surgery for familial adenomatous polyposis. World J Colorectal Surg. 2013;3(2).
  • Ozdemir Y, Kalady MF, Aytac E, et al. Anal transitional zone neoplasia in patients with familial adenomatous polyposis after restorative proctocolectomy and IPAA: incidence, management, and oncologic and functional outcomes. Dis Colon Rectum. 2013 Jul;56(7):808–814.
  • Gunther K, Braunrieder G, Bittorf BR, et al. Patients with familial adenomatous polyposis experience better bowel function and quality of life after ileorectal anastomosis than after ileoanal pouch. Colorectal Dis. 2003 Jan;5(1):38–44.
  • Bertario L, Russo A, Sala P, et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer. 2001 Mar 20;95(2):102–107. doi: 10.1002/1097-0215(20010320)95:2<102:AID-IJC1018>3.0.CO;2-8
  • Bertario L, Russo A, Radice P, et al. Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry. Ann Surg. 2000 Apr;231(4):538–543.
  • Colletti G, Ciniselli CM, Signoroni S, et al. Prevalence and management of cancer of the rectal stump after total colectomy and rectal sparing in patients with familial polyposis: results from a registry-based study. Cancers (Basel). 2022 Jan 8;14(2):298. doi: 10.3390/cancers14020298
  • Arnason T, Liang WY, Alfaro E, et al. Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps. Histopathology. 2014 Sep;65(3):353–362.
  • Bianchi LK, Burke CA, Bennett AE, et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008 Feb;6(2):180–185.
  • Hofgartner WT, Thorp M, Ramus MW, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol. 1999 Aug;94(8):2275–2281.
  • Leone PJ, Mankaney G, Sarvapelli S, et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc. 2019 May;89(5):961–968.
  • Mankaney GN, Cruise M, Sarvepalli S, et al. Surveillance for pathology associated with cancer on endoscopy (SPACE): criteria to identify high-risk gastric polyps in familial adenomatous polyposis. Gastrointest Endosc. 2020 Sep;92(3):755–762.
  • Marabelli M, Gismondi V, Ricci MT, et al. A novel APC promoter 1B deletion shows a founder effect in Italian patients with classical familial adenomatous polyposis phenotype. Genes Chromosomes Cancer. 2017 Dec;56(12):846–854.
  • Bulow S, Christensen IJ, Hojen H, et al. Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis. 2012 Aug;14(8):947–952.
  • Burke CA, Beck GJ, Church JM, et al. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc. 1999 Mar;49(3 Pt 1):358–364.
  • Roos VH, Bastiaansen BA, Kallenberg FGJ, et al. Endoscopic management of duodenal adenomas in patients with familial adenomatous polyposis. Gastrointest Endosc. 2021 Feb;93(2):457–466.
  • Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989 Sep 30;334(8666):783–785. doi: 10.1016/S0140-6736(89)90840-4
  • Thiruvengadam SS, Lopez R, O’Malley M, et al. Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis. Gastrointest Endosc. 2019 Feb;89(2):345–354 e2.
  • van Leerdam ME, Roos VH, van Hooft JE, et al. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2019 Nov;51(11):1082–1093.
  • Yang J, Gurudu SR, Koptiuch C, et al. American Society for Gastrointestinal endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc. 2020 May;91(5):963–982 e2.
  • Moussata D, Napoleon B, Lepilliez V, et al. Endoscopic treatment of severe duodenal polyposis as an alternative to surgery for patients with familial adenomatous polyposis. Gastrointest Endosc. 2014 Nov;80(5):817–825.
  • Aelvoet AS, Karstensen JG, Bastiaansen BAJ, et al. Cold snare polypectomy for duodenal adenomas in familial adenomatous polyposis: a prospective international cohort study. Endosc Int Open. 2023 Nov;11(11):E1056–E1062.
  • Jaganmohan S, Lynch PM, Raju RP, et al. Endoscopic management of duodenal adenomas in familial adenomatous polyposis–a single-center experience. Dig Dis Sci. 2012 Mar;57(3):732–737.
  • Huneburg R, Heling D, Kaczmarek DJ, et al. Dye chromoendoscopy leads to a higher adenoma detection in the duodenum and stomach in patients with familial adenomatous polyposis. Endosc Int Open. 2020 Oct;8(10):E1308–E1314.
  • Lami G, Galli A, Macri G, et al. Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation. World J Clin Oncol. 2017 Apr 10;8(2):168–177. doi: 10.5306/wjco.v8.i2.168
  • Abdelhafez M, Phillip V, Hapfelmeier A, et al. Comparison of cap-assisted endoscopy vs. side-viewing endoscopy for examination of the major duodenal papilla: a randomized, controlled, noninferiority crossover study. Endoscopy. 2019 May;51(5):419–426.
  • Mehta NA, Shah RS, Yoon J, et al. Risks, benefits, and effects on management for biopsy of the papilla in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2021 Apr;19(4):760–767.
  • Matsumoto T, Iida M, Nakamura S, et al. Natural history of ampullary adenoma in familial adenomatous polyposis: reconfirmation of benign nature during extended surveillance. Am J Gastroenterol. 2000 Jun;95(6):1557–1562.
  • Gluck N, Strul H, Rozner G, et al. Endoscopy and EUS are key for effective surveillance and management of duodenal adenomas in familial adenomatous polyposis. Gastrointest Endosc. 2015 Apr;81(4):960–966.
  • Labib PL, Goodchild G, Turbett JP, et al. Endoscopic ultrasound in the assessment of advanced duodenal adenomatosis in familial adenomatous polyposis. BMJ Open Gastroenterol. 2019;6(1):e000336. doi: 10.1136/bmjgast-2019-000336
  • Ma T, Jang EJ, Zukerberg LR, et al. Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome. Surg Endosc. 2014 Aug;28(8):2349–2356.
  • Yoon JY, Mehta N, Burke CA, et al. The prevalence and significance of jejunal and duodenal bulb polyposis after duodenectomy in familial adenomatous polyposis: retrospective cohort study. Ann Surg. 2021 Dec 1;274(6):e1071-e1077. doi: 10.1097/SLA.0000000000003740
  • van Houdt WJ, Husson O, Patel A, et al. Outcome of primary desmoid tumors at all anatomic locations initially managed with active surveillance. Ann Surg Oncol. 2019 Dec;26(13):4699–4706. doi: 10.1245/s10434-019-07826-6
  • Nathenson MJ, Hu J, Ratan R, et al. Systemic chemotherapies retain antitumor activity in desmoid tumors independent of specific mutations in CTNNB1 or APC: a multi-institutional retrospective study. Clin Cancer Res. 2022 Sep 15;28(18):4092–4104. doi: 10.1158/1078-0432.CCR-21-4504
  • Aitken SJ, Presneau N, Kalimuthu S, et al. Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses. Virchows Arch. 2015 Aug;467(2):203–210.
  • Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1990 Aug;33(8):639–642.
  • Nieuwenhuis MH, Casparie M, Mathus-Vliegen LM, et al. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer. 2011 Jul 1;129(1):256–261. doi: 10.1002/ijc.25664
  • Clark SK, Neale KF, Landgrebe JC, et al. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg. 1999 Sep;86(9):1185–1189.
  • Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut. 1994 Mar;35(3):377–381.
  • Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, et al. Desmoid tumors in patients with familial adenomatous polyposis. Cancer. 1994 Aug 15;74(4):1270–1274. doi: 10.1002/1097-0142(19940815)74:4<1270:AID-CNCR2820740415>3.0.CO;2-7
  • Soravia C, Berk T, McLeod RS, et al. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum. 2000 Mar;43(3):363–369.
  • Latchford A, Volikos E, Johnson V, et al. APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’. Hum Mol Genet. 2007 Jan 1;16(1):78–82. doi: 10.1093/hmg/ddl442
  • Durno C, Monga N, Bapat B, et al. Does early colectomy increase desmoid risk in familial adenomatous polyposis? Clin Gastroenterol Hepatol. 2007 Oct;5(10):1190–1194.
  • Friedl W, Caspari R, Sengteller M, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut. 2001 Apr;48(4):515–521.
  • Colombo C, Foo WC, Whiting D, et al. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center. Histol Histopathol. 2012 May;27(5):641–649.
  • Burgess A, Xhaja X, Church J. Does intra-abdominal desmoid disease affect patients with an ileal pouch differently than those with an ileorectal anastomosis? Dis Colon Rectum. 2011 Nov;54(11):1388–1391. doi: 10.1097/DCR.0b013e31822f8d91
  • Aelvoet AS, Struik D, Bastiaansen BAJ, et al. Colectomy and desmoid tumours in familial adenomatous polyposis: a systematic review and meta-analysis. Fam Cancer. 2022 Oct;21(4):429–439.
  • Koskenvuo L, Ristimaki A, Lepisto A. Comparison of sporadic and FAP-associated desmoid-type fibromatoses. J Surg Oncol. 2017 Nov;116(6):716–721. doi: 10.1002/jso.24699
  • Schiessling S, Kihm M, Ganschow P, et al. Desmoid tumour biology in patients with familial adenomatous polyposis coli. Br J Surg. 2013 Apr;100(5):694–703.
  • Benech N, Bonvalot S, Dufresne A, et al. Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis. 2022 Jun;54(6):737–746. doi: 10.1016/j.dld.2022.03.004
  • Penel N, Le Cesne A, Bonvalot S, et al. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French sarcoma group. Eur J Cancer. 2017 Sep;83:125–131. doi: 10.1016/j.ejca.2017.06.017
  • Bertagnolli MM, Eagle CJ, Zauber AG, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006 Aug 31;355(9):873–884. doi: 10.1056/NEJMoa061355
  • Ricciardiello L, Ahnen DJ, Lynch PM. Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):352–361. doi: 10.1038/nrgastro.2016.56
  • Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29;342(26):1946–1952. doi: 10.1056/NEJM200006293422603
  • Hall MJ. Updates in chemoprevention research for hereditary gastrointestinal and polyposis syndromes. Curr Treat Options Gastroenterol. 2021 Mar;19(1):30–46. doi: 10.1007/s11938-020-00306-x
  • Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary colorectal cancer syndromes: American society of clinical oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European society for medical oncology clinical practice guidelines. J Clin Oncol. 2015 Jan 10;33(2):209–217. doi: 10.1200/JCO.2014.58.1322
  • Ishikawa H, Mutoh M, Sato Y, et al. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):474–481.
  • Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011 May;140(6):1807–1816. doi: 10.1053/j.gastro.2011.01.057
  • Yang J, Wen Z, Li W, et al. Immune microenvironment: new insight for familial adenomatous polyposis. Front Oncol. 2021;11:570241. doi: 10.3389/fonc.2021.570241
  • Salehi-Abargouei A, Saraf-Bank S, Bellissimo N, et al. Effects of non-soy legume consumption on C-reactive protein: a systematic review and meta-analysis. Nutrition. 2015 May;31(5):631–639.
  • Steckhan N, Hohmann CD, Kessler C, et al. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis. Nutrition. 2016 Mar;32(3):338–348.
  • WCRF.org: Colorectal cancer [Internet]. Diet, nutrition, physical activity and cancer: a global perspective. London (UK). 2018. [cited 2024 Apr 8]. Available from: https://www.wcrf.org/diet-activity-and-cancer/cancer-types/colorectal-cancer/.
  • Morze J, Danielewicz A, Przybylowicz K, et al. An updated systematic review and meta-analysis on adherence to Mediterranean diet and risk of cancer. Eur J Nutr. 2021 Apr;60(3):1561–1586.
  • Fu Z, Shrubsole MJ, Smalley WE, et al. Lifestyle factors and their combined impact on the risk of colorectal polyps. Am J Epidemiol. 2012 Nov 1;176(9):766–776. doi: 10.1093/aje/kws157
  • Garcia-Montero C, Fraile-Martinez O, Gomez-Lahoz AM, et al. Nutritional components in western diet versus mediterranean diet at the gut microbiota–immune system interplay. implications for health and disease. Nutrients. 2021 Feb 22;13(2):699. doi: 10.3390/nu13020699
  • Tuttolomondo A, Simonetta I, Daidone M, et al. Metabolic and vascular effect of the Mediterranean diet. Int J Mol Sci. 2019 Sep 23;20(19):4716. doi: 10.3390/ijms20194716
  • Liu W, Zhang X, Xu H, et al. Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis. Gastroenterology. 2021 Jun;160(7):2395–2408.
  • Sinha SR, Haileselassie Y, Nguyen LP, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020 Apr 8;27(4):659–670 e5. doi: 10.1016/j.chom.2020.01.021
  • Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014 Oct;12(10):661–672. doi: 10.1038/nrmicro3344
  • Amoroso C, Perillo F, Strati F, et al. The role of gut microbiota biomodulators on mucosal immunity and intestinal inflammation. Cells. 2020 May 16;9(5):1234. doi: 10.3390/cells9051234
  • Mishima Y, Sartor RB. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. J Gastroenterol. 2020 Jan;55(1):4–14. doi: 10.1007/s00535-019-01618-1
  • Krautkramer KA, Fan J, Backhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021 Feb;19(2):77–94. doi: 10.1038/s41579-020-0438-4
  • Meslier V, Laiola M, Roager HM, et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 2020 Jul;69(7):1258–1268.
  • De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016 Nov;65(11):1812–1821.
  • Celiberto LS, Graef FA, Healey GR, et al. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology. 2018 Sep;155(1):36–52.
  • Zinocker MK, Lindseth IA. The western diet–microbiome-host interaction and its role in metabolic disease. Nutrients. 2018 Mar 17;10(3):365. doi: 10.3390/nu10030365
  • Christ A, Lauterbach M, Latz E. Western diet and the immune system: an inflammatory connection. Immunity. 2019 Nov 19;51(5):794–811. doi: 10.1016/j.immuni.2019.09.020
  • Belfiore A, Ciniselli CM, Signoroni S, et al. Preventive anti-inflammatory diet to reduce gastrointestinal inflammation in familial adenomatous polyposis patients: a prospective pilot study. Cancer Prev Res (Phila). 2021 Oct;14(10):963–972.
  • Maura CC, Eleonora B, Andreina O, et al. Management of dietary habits and diarrhea in fap individuals: a Mediterranean low-inflammatory dietary intervention. Nutrients. 2021 Nov 9;13(11):3988. doi: 10.3390/nu13113988
  • Pasanisi P, Gariboldi M, Verderio P, et al. A pilot low-inflammatory dietary intervention to reduce inflammation and improve quality of life in patients with familial adenomatous polyposis: protocol description and preliminary results. Integr Cancer Ther. 2019 Jan;18:1534735419846400. doi: 10.1177/1534735419846400
  • Francesca I, Patrizia P, Luca C, et al. Analysis of volatile compounds in powdered milk for infant nutrition by direct desorption (CIS4-TDU) and GC-MS. Talanta. 2015 Aug 15;141:195–199. doi: 10.1016/j.talanta.2015.04.026

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.